Navigation Links
Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results
Date:6/11/2009

HAE:TSX

MONTREAL, June 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) released today the results of its second quarter ended April 30, and reports on its recently concluded strategic collaboration with Angiotech Pharmaceuticals, Inc.

Stategic Collaboration

As previously announced on June 3, 2009, Angiotech Pharmaceuticals, Inc. and Haemacure have entered into a strategic collaboration which provides Angiotech with license, distribution and supply rights related to Haemacure's all-human fibrin sealant and thrombin products, both of which are currently in development.

Bridge Financing

Also on June 3, 2009, Angiotech and Haemacure entered into a bridge loan agreement in the minimum amount of US$2.5 million, to be advanced by Angiotech in multiple draw-downs. An amount of US$200,000 was received upon the signing of a term sheet on May 1st, 2009 and an amount of US$1 million was received upon the closing of the transaction. Angiotech may, at its sole discretion, advance up to an additional US$1 million to Haemacure from time to time, in multiple draw-downs, for a total loan of US$3.5 million. Haemacure estimates that the loan of US$2.5 million will allow it to continue operations until the end of calendar 2009.

"We believe this strategic collaboration and bridge financing with Angiotech provide an important validation of our company and its product candidates. This also positions us for a larger, subsequent capital raise in order to complete the development and launch our fibrin sealant and thrombin products on the market, said Joseph Galli, Chairman and Chief Executive Officer of Haemacure. "By collaborating with Angiotech, a company with a successful track record of innovation in drug delivery, we are expanding the number of product candidates that can be developed and leveraging our technology in new markets with significant unmet needs" concluded Mr. Gal
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacures All-Human Fibrin Sealant and Thrombin Products
2. Haemacure Update on Proposed Collaboration and Bridge Financing
3. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
4. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
5. Haemacure Restructures - Seeks Financing or Sale of the Company
6. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
7. Haemacure Announces Fiscal 2008 Results
8. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
9. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
10. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
11. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... 22, 2015 As interest in the value ... gains momentum worldwide, Rev. Eric J. Hall , president ... (HCCN), will be the keynote speaker on January 27 ... public health system. , The conference, “Hope and Resilience: Innovative ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
(Date:12/26/2014)... The US represents the largest market for CRC across ... estimates that sales of branded therapies were $2.23 billion. The ... incidence of the disease, high drug treatment rate, and higher ... sales of CRC therapies over the forecast period will be ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Mich. Scientists at Michigan State University have found ... inflammation in the mammary gland. This progesterone-induced ... risk of breast cancer. Progesterone is a naturally ... mammary gland. Progesterone previously has been identified as a ...
... the University of Pittsburgh School of Medicine have shown that ... is required for their biological activity. This shape-changing also allows ... to select the structure that permits the best binding. That ... that will have the most impact on protein function to ...
... , ORLANDO, Fla., Aug. 19 Valensa ... has dramatically increased the stability and shelf-life of the ... a 7-year shelf-life study of its Zanthin(R) natural astaxanthin ... of Haematococcus pluvialis, bolstered by Valensa,s proprietary O2B(R) Peroxidation ...
... , ... over 1,000 physicians across America regarding after-hours call management, human operator error was cited as ... frustration in their medical practice. , ... Knoxville, Tenn. (PRWEB) Aug. 19, 2009 -- In a survey of over 1,000 ...
... Programs Open Doors to Highlight Their Advanced Care Regimens ... of National Senior Citizens Day, this Friday, August 21(st), the National ... All-inclusive Care for the Elderly (PACE) around the country to educate ... Designed to serve individuals over 55 and in need of ...
... Maine, Aug. 19 Anthem Blue Cross and Blue Shield ... the administration of the H1N1 (swine flu) vaccine when it ... will be covered for members whose benefit plans provide coverage ... continue coverage of seasonal flu vaccine administration for those whose ...
Cached Medicine News:Health News:MSU scientists: Progesterone leads to inflammation 2Health News:Pitt scientists find intrinsic changes in protein shape influence drug binding 2Health News:Astaxanthin Stability Breakthrough Achieved by Valensa 2Health News:Astaxanthin Stability Breakthrough Achieved by Valensa 3Health News:Physicians Citing Human Error as Top Communication Problem 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 3Health News:Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 2
(Date:1/22/2015)... Inc. (NASDAQ: UPI ), a medical device company ... treat voiding dysfunctions, today reported financial results for the ... Global revenue for the Company,s Urgent ®  PC Neuromodulation ... revenue record, as compared to $3.9 million in the ...
(Date:1/22/2015)...  Amgen (NASDAQ: AMGN ) today announced that it will ... Tuesday, Jan. 27, 2015, after the close of the U.S. financial ... the investment community at 2 p.m. PT. Participating in the call ... chief executive officer, and other members of Amgen,s senior management team. ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015 Increasing sophistication ... continued consolidation of localization purchasing in 2015, says ... According to a recent study by market research firm ... a single-source solution for their translation and localization needs. ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
4 mm blade. Bayonet. Flat handle....
1 mm diameter. Angled 33 degrees. Round handle....
5 mm curved blade. Round handle....
0.75 mm diameter blade. Angled 60 degrees. Round handle. Designated most popular model or size....
Medicine Products: